Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Stroke survivors with atrial fibrillation may be at greater risk of developing Dementia

Stroke survivors with atrial fibrillation may be at greater risk of developing Dementia

New insight into coronary artery disease

New insight into coronary artery disease

Doctors at Beaumont Hospital, Troy perform robotic-assisted maze procedure to correct atrial fibrillation

Doctors at Beaumont Hospital, Troy perform robotic-assisted maze procedure to correct atrial fibrillation

Medtronic launches Achieve Mapping Catheter in Europe

Medtronic launches Achieve Mapping Catheter in Europe

CardioFocus completes $30.6M private financing

CardioFocus completes $30.6M private financing

HRS invites NewCardio to present CardioBip system clinical study results at Annual Scientific Meeting

HRS invites NewCardio to present CardioBip system clinical study results at Annual Scientific Meeting

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

Regeneron submits VEGF Trap-Eye BLA to FDA for treatment of wet AMD

Regeneron submits VEGF Trap-Eye BLA to FDA for treatment of wet AMD

Elsevier, CJC publish 2011 issue of Canadian Journal of Cardiology

Elsevier, CJC publish 2011 issue of Canadian Journal of Cardiology

In the Gulf states rates of heart disease are rising with the economy

In the Gulf states rates of heart disease are rising with the economy

CCS Atrial Fibrillation Guidelines help Canadian physicians recognize and treat heart conditions

CCS Atrial Fibrillation Guidelines help Canadian physicians recognize and treat heart conditions

Medtronic: Kyphon Balloon Kyphoplasty provides better back pain relief in cancer patients

Medtronic: Kyphon Balloon Kyphoplasty provides better back pain relief in cancer patients

Sanofi-Aventis, Boehringer, World Heart Federation collaborate to raise awareness about AF

Sanofi-Aventis, Boehringer, World Heart Federation collaborate to raise awareness about AF

BCVI offers multidisciplinary approach to treat patients with atrial fibrillation

BCVI offers multidisciplinary approach to treat patients with atrial fibrillation

Endosense announces completion of enrollment in EFFICAS I clinical study

Endosense announces completion of enrollment in EFFICAS I clinical study

Dabigatran drug helps prevent blood clots in patients with atrial fibrillation

Dabigatran drug helps prevent blood clots in patients with atrial fibrillation

Heavy alcohol intake can lead to increased risk of AF

Heavy alcohol intake can lead to increased risk of AF

New tool helps doctors assess likelihood of death from stroke

New tool helps doctors assess likelihood of death from stroke

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

International Stroke Conference: News releases and news tips

International Stroke Conference: News releases and news tips

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.